Alps Advisors Inc Abb Vie Inc. Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

A detailed history of Alps Advisors Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 167,216 shares of ABBV stock, worth $29.8 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

167,216

Previous 201,588 17.05%

Holding current value

$29.8 Million

Previous $34.6 Million 4.5%

% of portfolio

0.22%

Previous 0.24%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $5.63 Million - $6.85 Million	-34,372 Reduced 17.05%	167,216 $33 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $708,473 - $827,338	4,577 Added 2.32%	201,588 $34.6 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $4.17 Million - $4.75 Million	-26,090 Reduced 11.69%	197,011 $35.9 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $525,907 - $592,295	-3,822 Reduced 1.68%	223,101 $34.6 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $1.51 Million - $1.75 Million	-11,287 Reduced 4.74%	226,923 $33.8 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $106,405 - $132,414	803 Added 0.34%	238,210 $32.1 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $487,480 - $561,406	3,371 Added 1.44%	237,407 $37.8 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $3.6 Million - $4.32 Million	-26,024 Reduced 10.01%	234,036 $37.8 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $1.8 Million - $2.07 Million	13,421 Added 5.44%	260,060 $34.9 Million
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $6.32 Million - $8.03 Million	45,894 Added 22.86%	246,639 $37.8 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $3.88 Million - $4.81 Million	-29,387 Reduced 12.77%	200,745 $32.5 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $516,416 - $653,415	-4,807 Reduced 2.05%	230,132 $31.2 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $445,071 - $505,222	4,183 Added 1.81%	234,939 $25.3 Million
Q2 2021 Aug 11, 2021	BUY	$105.21 - $117.21 $370,128 - $412,344	3,518 Added 1.55%	230,756 $26 Million
Q1 2021 May 07, 2021	BUY	$102.3 - $112.62 $1.9 Million - $2.09 Million	18,548 Added 8.89%	227,238 $24.6 Million
Q4 2020 Feb 03, 2021	SELL	$80.49 - $108.67 $903,741 - $1.22 Million	-11,228 Reduced 5.11%	208,690 $22.4 Million
Q3 2020 Nov 04, 2020	SELL	$85.91 - $100.83 $737,279 - $865,323	-8,582 Reduced 3.76%	219,918 $19.3 Million
Q2 2020 Aug 05, 2020	SELL	$73.37 - $98.18 $4.42 Million - $5.92 Million	-60,275 Reduced 20.87%	228,500 $22.4 Million
Q1 2020 May 06, 2020	SELL	$64.5 - $97.79 $9.04 Million - $13.7 Million	-140,221 Reduced 32.69%	288,775 $22 Million
Q4 2019 Feb 07, 2020	SELL	$72.13 - $90.25 $7.05 Million - $8.83 Million	-97,800 Reduced 18.57%	428,996 $38 Million
Q3 2019 Nov 04, 2019	BUY	$62.98 - $75.72 $2.24 Million - $2.69 Million	35,558 Added 7.24%	526,796 $39.9 Million
Q2 2019 Aug 07, 2019	SELL	$65.7 - $83.98 $2.31 Million - $2.95 Million	-35,184 Reduced 6.68%	491,238 $35.7 Million
Q1 2019 May 01, 2019	BUY	$77.14 - $90.79 $2.39 Million - $2.81 Million	30,929 Added 6.24%	526,422 $42.4 Million
Q4 2018 Feb 04, 2019	BUY	$77.85 - $96.01 $36.9 Million - $45.5 Million	474,055 Added 2211.28%	495,493 $45.7 Million
Q3 2018 Oct 25, 2018	BUY	$88.91 - $98.84 $71,928 - $79,961	809 Added 3.92%	21,438 $2.03 Million
Q2 2018 Aug 02, 2018	BUY	$89.78 - $106.23 $794,553 - $940,135	8,850 Added 75.13%	20,629 $1.91 Million
Q2 2018 Jul 25, 2018	SELL	$89.78 - $106.23 $982,642 - $1.16 Million	-10,945 Reduced 48.16%	11,779 $1.14 Million
Q1 2018 May 01, 2018	BUY	$92.01 - $123.21 $1.01 Million - $1.35 Million	10,945 Added 92.92%	22,724 $2.15 Million
Q4 2017 Feb 05, 2018	SELL	$89.56 - $98.21 $47.6 Million - $52.2 Million	-531,104 Reduced 97.83%	11,779 $1.14 Million
Q3 2017 Nov 03, 2017	BUY	$69.85 - $89.22 $37.9 Million - $48.4 Million	542,883	542,883 $48.2 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Abb Vie Inc. Transaction History